We characterized antibiotic resistance and virulence of uropathogenic Escherichia coli (UPEC) strains isolated from urinary tract infections (UTIs) in patients hospitalized in urology departments. A prospective multicentre study was initiated from March 2009 and lasted until February 2010 in French urology units. All patients with asymptomatic bacteriuria (ABU), acute cystitis, acute pyelonephritis or acute prostatitis in whom UPEC was detected were included. Antimicrobial resistance and virulence factors were compared among the different groups. To identify Abbreviations: ABU, asymptomatic bacteriuria; ESBL, extended spectrum b-lactamase; QRDR, quinolone resistance-determining region; rep-PCR, repetitive-PCR ; UPEC, uropathogenic Escherichia coli; UTI, urinary tract infections; VF, virulence factor.
INTRODUCTION
Urinary tract infections (UTIs) are among the most common community-acquired and nosocomial infections (Foxman, 2003; Lavigne et al., 2007) . These infections are rarely directly associated with a patient's death. However, they are responsible for an increased risk of aggravation of comorbidity and healthcare-associated costs. Such infections are also responsible for significant use of antibiotics, with implications for bacterial ecology and the risk of collateral damage. Among bacterial species implicated in UTIs, uropathogenic Escherichia coli (UPEC) is the most common. In recent decades, multidrug-resistant UPEC has led to major difficulties treating infected patients. Although many recent studies have investigated UPEC virulence, few data are available on antibiotic resistance and the virulence features of these strains directly isolated from UTIs in patients hospitalized in urology departments (Merle et al., 2002; Wada et al., 2009; Medina-Polo et al., 2015) . Thus, we conducted a prospective multicentre study in French urology units to better characterize UPEC in terms of resistance and virulence.
METHODS
Study design and bacterial isolates. This study was approved by the local Institutional Review Board. The prospective study was initiated on 1 March 2009 and carried out until 28 February 2010 in French urology wards from different centres. All patients with a urinary colonization [asymptomatic bacteriuria (ABU)], acute cystitis, acute pyelonephritis or acute prostatitis in whom E. coli was detected in monoculture were included consecutively. A urine sample was considered positive when 10 3 c.f.u. E. coli ml -1 was detected. Each patient was included once. ABU was defined as the presence of E. coli in the urine without causing symptoms. Urine samples were collected before urological surgery intervention from patients without clinical signs. Strains causing cystitis, pyelonephritis and prostatitis were isolated in monocultures from the urine of patients diagnosed with acute cystitis, acute pyelonephritis and acute prostatitis, respectively. Every patient was examined by trained physicians for inclusion in a clinical category, according to the Guidelines from the European Association of Urology 2009 (http://www.uroweb. org/fileadmin/tx_eauguidelines/2009/Full/Urological_Infections.pdf). For each patient, the evaluated demographic and clinical data were: sex, age, Charlson's score (Charlson et al., 2008 ), MacCabe's score (MacCabe & Jackson, 1962) , prior use of antibiotics (b-lactam antibiotics and fluoroquinolones) in the previous 3 months and death during hospitalization. The presence of a urinary catheter (double pigtail catheter, ureteral catheter, vesical catheter or suprapubic catheter) or history of recurrent infection, as well as occurrence of a previous community or nosocomialacquired infection, were also noted.
The genus and species of each isolate were determined biochemically with a Vitek 2 identification card (bioM erieux) and all strains were sent to the same laboratory that performed the test.
Susceptibility testing. Susceptibility to the main antimicrobial agents used in urology was tested by using a Vitek 2 card (bio-M erieux). Strains were classified as susceptible, intermediately resistant or resistant to the antibiotics tested according to SFM/EUCAST guidelines (http://www.sfm-microbiologie.org). Extended spectrum b-lactamase (ESBL) production was confirmed by a double-disc synergy test (Jarlier et al., 1988) .
Characterization of b-lactamase-encoding genes and quinolone resistance. Plasmid and chromosomal DNA were extracted from the isolates with a Qiagen Plasmid DNA Midi kit and EZ1 DNA Tissue kit on the BioRobot EZ1 extraction platform (Qiagen), respectively. The genotypic characterization of ESBL and qnr resistance mechanisms was determined by microarray assays (Identibac AMR-ve) targeting 54 resistance genes, notably the bla TEM , bla SHV , bla CTX-M , bla KPC , bla OXA-23 , bla IMP-1 , bla VIM-1 , qnrA, qnrB and qnrS genes (Batchelor et al., 2008) . Results were confirmed by a PCR assay targeting genes detected by the array and subsequent sequencing of the PCR products (Afzal-Shah et al., 2001; Pitout et al., 2004; Kim et al., 2005) . A triplex PCR specific for the international clone CTX-M-15-producing E. coli O25b : H4-ST131 was performed (Blanco et al., 2009) . Genetic characterization of the quinolone resistance-determining region (QRDR) (gyrA, gyrB, parC and parE mutations) was performed by PCR and gene sequencing (Mammeri et al., 2005) . In all PCR experiments, positive and negative controls were included.
Repetitive-PCR (rep-PCR). The worldwide-distributed E. coli clone O25-ST131 corresponds to a group of strains with 68-100 % similarity by PFGE (Nicolas-Chanoine et al., 2008) . MTPA1, a French community strain found in the south of France and belonging to the O25-ST131 clone, was used to detect an eventual relationship between the studied isolates and this clone. All DNA samples were amplified using a DiversiLab E. coli kit for DNA fingerprinting (BioM erieux) following the manufacturer's instructions. The PCR protocol was described previously by Bonacorsi et al. (2009) . Detection and analysis of rep-PCR products were implemented using the Diversilab system (Bacterial Barcodes), which separates fragments by electrophoresis performed in a microfluidics DNA LabChip. Analysis was performed with DiversiLab software version 3.3 and using the Pearson correlation coefficient to calculate similarity among all possible pairs of sample fingerprints. The unweighted pair group method with arithmetic mean was used to automatically compare the rep-PCR profiles and create the corresponding dendrograms.
Phylogenetic grouping. Phylogenetic grouping and the O group of the ESBL-producing E. coli isolates were determined by PCR-based methods developed by Clermont et al. (2007 Clermont et al. ( , 2013 .
Virulence genotypes. To assess the strain virulence potentiality, two complementary strategies were carried out. First, we used a miniaturized E. coli oligonucleotide virulence array (Identibac E. coli; Alere). This array contains 92 targets including 39 virulence, 7 bacteriocin and 15 control (rrl and gad) gene probes (Anjum et al., 2007) . Secondly, 19 extraintestinal virulence-associated genes were evaluated by . in-house PCR: the three papG alleles (encoding the P fimbriae), papA, papC and papE (encoding the P fimbriae structural subunit and assembly), sfaS and focG (S fimbriae and F1C fimbriae), afa/ draBC (Dr family adhesin), fimH (mannose-specific adhesin subunit of type 1 fimbriae), hlyA (haemolysin), cnf1 (cytotoxic necrotizing factor-1), iutA (aerobactin), kpsMTK1 and kpsMTII (group II capsules synthesis), traT (serum resistance), iroN (iron acquisition), malX (a marker for a pathogenicity-associated island from archetypal uropathogenic strain CFT073), irp2 (iron regulatory protein) and ompT (outer membrane protein T) (Johnson et al., 2002; Nicolas-Chanoine et al., 2008) .
Statistical analysis. For each virulence factor (VF), comparisons between the different groups (ABU, cystitis, pyelonephritis and prostatitis) were evaluated using 2 or Fisher's exact test. To identify independent associations between virulence markers and the risk of UTI, we used a multivariate logistic regression with a backwards procedure. Odds ratios were reported with 95 % confidence intervals. The analysis was carried out using S-plus 8.0 for Windows (Insightful).
RESULTS

Studied population
During the studied period, 210 patients were consecutively included and the isolates were collected from different urology departments all over France (Table 1 ). The mean age was 65.8 years (± 18.2 years) and the sex ratio was 106 female : 104 male. An ABU was diagnosed in 67 cases (31.9 %), acute cystitis in 52 cases (24.7 %), acute pyelonephritis in 35 cases (16.7 %) and acute prostatitis in 56 cases (26.7 %). Episodes of UTI were community acquired in 152 cases (72.4 %). Charlson's score was 0 in 45 patients, <1 to >3 in 122 patients, 4 and >5 in 22 patients and 6 in 22 patients. No association between score and UTI localization was observed. However, ABU was significantly more frequent in patients with hemiplegia (P<0.001). Prostatitis was significantly more frequent in patients with dementia (P=0.04). MacCabe's score was 0 in 113 patients, 1 in 63 patients and 2 in 15 patients. Prior use of antibiotics (b-lactam antibiotics and/or fluoroquinolones) within the previous 3 months was observed in 71 patients (37.2 %) among the 191 evaluable patients. The presence of a urinary catheter during hospitalization was noted in 118 patients (56.2 %). Among them, 68 (57.6 %) patients had an indwelling urinary catheter. Among patients with ABU, 76.1 % (51/67) had a urinary catheter versus 23.9 % (16/67) in patients with infection (P<0.001). A history of recurrent infection was observed in 35 patients (16.7 %). Death during hospitalization occurred in six patients (2.9 %).
Characteristics of the UPEC resistance
The resistance rate was 61.4 % for amoxicillin, 37.6 % for amoxicillin-clavulanic acid, 31.9 % for nalidixic acid, 24.8 % for ciprofloxacin, 3.8 % for nitrofurantoin and 37.1 % for cotrimoxazole. Resistance rates to antibiotics were not correlated to the localization of the UTI (P value between 0.06 and 0.97), nor to the presence of a urinary catheter (P=0.06) or the history of recent antibiotic treatment (P=0.15). All isolates were susceptible to carbapenems (Table 2) .
Sixteen strains (7.6 %) were resistant to third-generation cephalosporins; all produced an ESBL. These ESBL were CTX-M-15 (n=8, 50 %), CTX-M-14 (n=2, 12.5 %) and TEM-24 (n=6, 37.5 %). Five CTX-M-15-producing E. coli (63 %) belonged to the pandemic clone O25b-ST131 and are clonal by Rep-PCR.
For fluoroquinolones, resistance mediated by qnr genes (qnrA, qnrB and qnrS) was not detected. Genetic characterization of the QRDR revealed substitutions at codon 83 (Ser83fiTyr and Ser 83fiLeu) and/or 87 (Asp87fiAsn) in the gyrA gene in all the 67 strains (52 strains possessed both mutations). Among the 67 strains with gyrA mutations, 44 had additional mutations at codons 80 (Ser80fiIle) and/or 84 (Glu84fiVal and Glu84fiAla) in the parC gene. None of the strains tested harboured a parC mutation alone. Finally, 20 % of the strains showed a single mutation in parE encoding Ser458fiAla. No mutation was found in the gyrB gene. No significant difference could be noted between the resistance levels to the different antibiotics and the origin of the infection (community vs nosocomial) (P value between 0.2 and 0.98).
Characteristics of the UPEC virulence
The strains isolated from infections belonged more frequently to B2 and D phylotypes compared with strains isolated from colonization (P=0.007) ( Table 3) . papG allele II, papA, papC, papE, kpsMTII and iutA genes were significantly more frequent in infecting strains compared with colonizing strains (P<0.05). Among the VFs studied, the papG allele II, papA, papC and iutA genes were found significantly more frequently in strains isolated from pyelonephritis compared with other categories (P<0.001, 0.002, 0.04 and 0.02, respectively). The kpsMTII gene was significantly more frequent in strains isolated from prostatitis compared with other groups (P=0.01). In multivariate analysis, the papA and kpsMTII genes were significantly associated with the presence of an infection (Table 4 ).
There was no significant difference in the distribution of virulence genes between ESBL-producing E. coli isolates and those susceptible to cefotaxime, except for iutA, which was significantly more common in susceptible strains (P=0.046). Increased virulence was observed among E. coli susceptible to ciprofloxacin compared with resistant strains. The papG alleles II and III and papA, papE, hlyA, KpsMTII, kpsMTK1, cnf1, sfa and foc genes were significantly more common in susceptible strains (P<0.01). In multivariate analysis, strains susceptible to ciprofloxacin were significantly more frequently associated with papG allele II (P=0.007) and the kpsMTK1 (P<0.001) and hlyA (P<0.001) genes than the ciprofloxacin-resistant strains (Table 5) .
DISCUSSION
To the best of our knowledge, this is the first study investigating the resistance and virulence potential of UPEC strains isolated from patients hospitalized in urology departments. The population of this study was different from populations studied previously in the literature. Indeed, several differences may be noted: (i) the sex ratio was balanced, whereas traditionally UTIs are more prevalent in women; (ii) the frequency of the presence of a vesical catheter was in more than half of the patients (56.2 %); and (iii) the population with a urinary colonization (31.9 %) accounted for nearly one-third of patients, which can be explained by the high incidence of bladder diseases hospitalized in urology units.
The resistance rates for amoxicillin and amoxicillin-clavulanic acid were higher than those described by the national network of l'Observatoire National de l'Epid emiologie de la R esistance Bact erienne aux Antibiotiques (ONERBA; http:// www.onerba.org). However, these data did not distinguish between strains from urine and those of other origins. The current concern in the field of antibiotic therapy of UTIs is the increasing resistance of E. coli against third-generation cephalosporins and fluoroquinolones. Regarding E. coli resistant to third-generation cephalosporins, we observed rates similar to those observed at the national level, regardless of the inpatient unit. Currently, in France, almost 7 % of E. coli isolates are resistant to these antibiotics (http:// www.onerba.org; http://www.eucast.org). Since 2000, the incidence of ESBLs has increased, including in communityacquired infections. This is related to the emergence and rapid spread around the world from a new group of plasmid-mediated ESBLs, namely CTX-M enzymes (Canton & Coque, 2006) . Among the CTX-M enzymes, CTX-M-15 has been shown to be the most frequent with a worldwide clonal propagation (Coque et al., 2008; NicolasChanoine et al., 2008) . In the present study, we observed the predominance of CTX-M among ESBLs (62.5 %), with a clear majority of CTX-M-15 (80 %), and the presence of the widespread clone O25b-ST131. For fluoroquinolones, we found a resistance rate close to 25 %, higher than that described by ONERBA (~18 % for strains of any origin; http://www.onerba.org). In our study, no fluoroquinolone resistance mediated by qnr genes was found, despite the emergence of this resistance mechanism. Indeed, qnr-positive isolates were identified in E. coli isolated from community-acquired and healthcare-associated UTIs (Barguigua et al., 2013) . All isolates were susceptible to carbapenems. Recently, the emergence of carbapenem resistance in Enterobacteriaceae was noted in France. However, this evolution concerned Klebsiella pneumoniae more frequently than E. coli isolates (Potron et al., 2013) .
Concerning the virulence genotypes observed in the studied strains, our results highlight some important points: (i) quinolone-resistant strains lack extraintestinal VFs, as described previously (Johnson et al., 2002 Vila et al., 2002 Branger et al., 2005; Drew et al., 2005; Horcajada et al. 2005) . These strains are predominantly in non-B2 and D phylogenic backgrounds (25.5 % of the strains); (ii) ESBLproducing strains belonged more frequently to B2 phylotype compared with quinolone-resistant strains (50 vs 34.6 %, respectively) but presented a lower prevalence of VFs compared with susceptible strains as noted previously (Lavigne et al., 2006); (iii) papA and kpsMTII were significantly associated with UTIs; (iv) the papG allele II was a marker of pyelonephritis, as suggested previously (Qin et al., 2013) ; and (v) colonization regrouped significantly more commensal E. coli strains belonging to phylogroups A and B1, explaining the low virulence of these strains.
CONCLUSION
To date, few data have been published on E. coli resistance of isolates from patients hospitalized in urology units. Monitoring networks mainly provide data on E. coli isolated from invasive infections or global data. Our study confirmed data published previously about these VFs. However, the resistance rate of isolates to antibiotics was higher than that described by the monitoring networks. This is most likely related to the types of patients hospitalized in these departments. These observations lead to two suggestions necessary to conduct a rational policy prescription of antibiotics: (i) the awareness of the resistance rates of E. coli in urology departments; and (ii) the necessity to establish guidelines for appropriate probabilistic first-line antibiotic treatment taking into account these resistance rates, especially for the controlled use of fluoroquinolones. 
